{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:11:15Z","timestamp":1790795475884,"version":"4.1.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1210\/jc.2017-02340","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T21:50:18Z","timestamp":1523051418000},"page":"1296-1301","source":"Crossref","is-referenced-by-count":28,"title":["Recent Topics Around Multiple Endocrine Neoplasia Type 1"],"prefix":"10.1210","volume":"103","author":[{"given":"Stephen J","family":"Marx","sequence":"first","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"2019041122470468700_B1","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"7","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122470468700_B2","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7643","key":"2019041122470468700_B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"issue":"7","key":"2019041122470468700_B4","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2011-3355","article-title":"Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years","volume":"97","author":"Neary","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041122470468700_B5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041122470468700_B6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 Study Group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041122470468700_B7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.celrep.2017.02.025","article-title":"Enhancer-mediated oncogenic function of the menin tumor suppressor in breast cancer","volume":"18","author":"Dreijerink","year":"2017","journal-title":"Cell Reports"},{"issue":"3","key":"2019041122470468700_B8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"2019041122470468700_B9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2796.1998.00280.x","article-title":"The ultimate biochemical diagnosis of endocrine pancreatic tumors in MEN-1","volume":"243","author":"Oberg","year":"1998","journal-title":"J Intern Med"},{"issue":"10","key":"2019041122470468700_B10","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1210\/jc.2013-1800","article-title":"Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients","volume":"98","author":"de Laat","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122470468700_B11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/cen.13119","article-title":"Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients","volume":"85","author":"Qiu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019041122470468700_B12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/ije.15.29","article-title":"Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies","volume":"3","author":"Ito","year":"2016","journal-title":"Int J Endocr Oncol"},{"issue":"1","key":"2019041122470468700_B13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gie.2014.09.037","article-title":"EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1","volume":"81","author":"van Asselt","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2019041122470468700_B14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jamcollsurg.2015.04.005","article-title":"Results of (68)gallium-dotatate PET\/CT scanning in patients with multiple endocrine neoplasia type 1","volume":"221","author":"Sadowski","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2019041122470468700_B15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2967\/jnmt.111.098277","article-title":"The SNM practice guideline for somatostatin receptor scintigraphy 2.0","volume":"39","author":"Balon","year":"2011","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"2019041122470468700_B16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.1.01901","article-title":"Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies","volume":"152","author":"Vezzosi","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041122470468700_B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jc.2016-3445","article-title":"Localization of insulinoma using 68Ga-dotatate PET\/CT scan","volume":"102","author":"Nockel","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122470468700_B18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2012.00158","article-title":"Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications","volume":"3","author":"K\u00f6rner","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2019041122470468700_B19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev-physiol-021113-170315","article-title":"Glucagon-like peptide-1: glucose homeostasis and beyond","volume":"76","author":"Cho","year":"2014","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"2019041122470468700_B20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with 68Ga-NOTA-exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","author":"Luo","year":"2016","journal-title":"J Nucl Med"},{"issue":"1","key":"2019041122470468700_B21","doi-asserted-by":"crossref","first-page":"e0170435","DOI":"10.1371\/journal.pone.0170435","article-title":"Radioiodinated exendin-4 is superior to the radiometal-labelled glucagon-like peptide-1 receptor probes overcoming their high kidney uptake","volume":"12","author":"L\u00e4ppchen","year":"2017","journal-title":"PLoS One"},{"key":"2019041122470468700_B22","first-page":"EP607","article-title":"Glucagon-like-1 receptor imaging specifically localizes insulinomas in patients with multiple endocrine neoplasia type 1 (MEN-1)","volume-title":"Endocrine Abstracts","author":"Antwi","year":"2016"},{"issue":"10","key":"2019041122470468700_B23","doi-asserted-by":"crossref","first-page":"T243T260","DOI":"10.1530\/ERC-17-0285","article-title":"The future: surgical advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Sadowski","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2019041122470468700_B24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SLA.0000000000002050","article-title":"Early and late complications after surgery for MEN1-related nonfunctioning pancreatic neuroendocrine tumors","volume":"267","author":"Nell","year":"2018","journal-title":"Ann Surg"},{"key":"2019041122470468700_B25","doi-asserted-by":"crossref","unstructured":"Nell S , VerkooijenHM, PietermanCR, de HerderWW, HermusAR, DekkersOM, van der Horst-SchriversAN, DrentML, BisschopPH, HavekesB, Borel RinkesIH, VriensMR, ValkGD. Management of MEN1 related nonfunctioning pancreatic NETs: a shifting paradigm: results from the DutchMEN1 Study Group [published online ahead of print March 2, 2016]. Ann Surg. doi: 10.1097\/SLA.0000000000002183.","DOI":"10.1097\/SLA.0000000000002183"},{"issue":"1","key":"2019041122470468700_B26","first-page":"27","article-title":"Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study","volume":"49","author":"Kappelle","year":"2017","journal-title":"Endoscopy"},{"issue":"10","key":"2019041122470468700_B27","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small non-functional pancreatic neuroendocrine tumors in MEN1\u2013results from the Dutch MEN1 Study Group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122470468700_B28","doi-asserted-by":"crossref","unstructured":"Triponez F , SadowskiSM, PattouF, Cardot-BautersC, Miralli\u00e9E, Le BrasM, SebagF, NiccoliP, DeguelteS, CadiotG, PoncetG, LifanteJC, Borson-ChazotF, ChaffanjonP, ChabreO, MenegauxF, BaudinE, RuszniewskiP, Du BoullayH, GoudetP. Long-term follow-up of MEN1 patients who do not have initial surgery for small \u22642 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE study: Association Francophone de Chirurgie Endocrinienne & Groupe d\u2019Etude des Tumeurs Endocrines [published online ahead of print March 15, 2017]. Ann Surg. doi: 10.1097\/SLA.0000000000002191.","DOI":"10.1097\/SLA.0000000000002191"},{"key":"2019041122470468700_B29","first-page":"206502","article-title":"Minimally invasive parathyroidectomy","volume-title":"Int J Endocrinol","author":"Starker","year":"2011"},{"issue":"2","key":"2019041122470468700_B30","first-page":"141","article-title":"Minimally invasive pancreatic surgery - a review","volume":"10","author":"Damoli","year":"2015","journal-title":"Wideochir Inne Tech Malo Inwazyjne"},{"issue":"4","key":"2019041122470468700_B31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000445007","article-title":"Minimally invasive surgery for pancreatic disease - current status","volume":"33","author":"Alsfasser","year":"2016","journal-title":"Dig Surg"},{"issue":"4","key":"2019041122470468700_B32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jso.24315","article-title":"Robot-assisted spleen preserving pancreatic surgery in MEN1 patients","volume":"114","author":"Nell","year":"2016","journal-title":"J Surg Oncol"},{"issue":"20","key":"2019041122470468700_B33","doi-asserted-by":"crossref","first-page":"33872","DOI":"10.18632\/oncotarget.17513","article-title":"Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"2019041122470468700_B34","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019041122470468700_B35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"2019041122470468700_B36","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2019041122470468700_B37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Pediatr"},{"issue":"4","key":"2019041122470468700_B38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","article-title":"Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo","volume":"27","author":"Borkin","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"2019041122470468700_B39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.0408836102","article-title":"Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors","volume":"102","author":"Milne","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7386","key":"2019041122470468700_B40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10806","article-title":"The same pocket in menin binds both MLL and JUND but has opposite effects on transcription","volume":"482","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"3","key":"2019041122470468700_B41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J Med Genet"},{"issue":"1","key":"2019041122470468700_B42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncpendmet0718","article-title":"Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene","volume":"4","author":"Hannan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"5","key":"2019041122470468700_B43","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2019041122470468700_B44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"2019041122470468700_B45","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in MEN1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122470468700_B46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2265.2000.00966.x","article-title":"Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1","volume":"52","author":"Hai","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2019041122470468700_B47","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122470468700_B48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin Transl Sci"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1296\/25088475\/jc.2017-02340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T07:32:17Z","timestamp":1604129537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1296\/4963823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,6]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02340","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4,1]]}}}